These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8840412)

  • 1. The pharmacological profile of famciclovir.
    Crumpacker C
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir: review of clinical efficacy and safety.
    Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
    Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Wagstaff AJ
    Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir/penciclovir.
    Sacks SL; Wilson B
    Adv Exp Med Biol; 1999; 458():135-47. PubMed ID: 10549386
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats.
    Thomasy SM; Maggs DJ; Moulin NK; Stanley SD
    Am J Vet Res; 2007 Nov; 68(11):1252-8. PubMed ID: 17975982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
    Chakrabarty A; Tyring SK; Beutner K; Rauser M
    Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famciclovir for treatment of herpesvirus infections.
    Luber AD; Flaherty JF
    Ann Pharmacother; 1996 Sep; 30(9):978-85. PubMed ID: 8876860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
    Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
    J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of penciclovir in healthy cats following oral administration of famciclovir or intravenous infusion of penciclovir.
    Thomasy SM; Whittem T; Bales JL; Ferrone M; Stanley SD; Maggs DJ
    Am J Vet Res; 2012 Jul; 73(7):1092-9. PubMed ID: 22738064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
    Simpson D; Lyseng-Williamson KA
    Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infections.
    Tyring S
    Skin Therapy Lett; 2001 Nov; 6(12):1-2, 5. PubMed ID: 11753535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of famciclovir and penciclovir in tears following oral administration of famciclovir to cats: a pilot study.
    Thomasy SM; Covert JC; Stanley SD; Maggs DJ
    Vet Ophthalmol; 2012 Sep; 15(5):299-306. PubMed ID: 22339892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
    Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
    J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical pharmacokinetics of famciclovir.
    Gill KS; Wood MJ
    Clin Pharmacokinet; 1996 Jul; 31(1):1-8. PubMed ID: 8827396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
    Sáez-Llorens X; Yogev R; Arguedas A; Rodriguez A; Spigarelli MG; De León Castrejón T; Bomgaars L; Roberts M; Abrams B; Zhou W; Looby M; Kaiser G; Hamed K
    Antimicrob Agents Chemother; 2009 May; 53(5):1912-20. PubMed ID: 19273678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
    Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
    Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
    Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir].
    Vere Hodge RA; Sutton D; Boyd MR; Harnden MR; Jarvest RL
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1765-73. PubMed ID: 2589844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.